Mangoceuticals Inc.

AI Score

0

Unlock

2.52
-0.06 (-2.33%)
At close: Jan 15, 2025, 1:41 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21
Net Income -9.21M -2.00M -17.70K
Depreciation & Amortization 24.89K 3.86K n/a
Stock-Based Compensation 624.46K 234.09K n/a
Other Working Capital -65.58K -14.81K n/a
Other Non-Cash Items 1.52M 546.54K 181.00
Deferred Income Tax n/a -151.82K n/a
Change in Working Capital 41.51K 18.87K n/a
Operating Cash Flow -7.00M -1.35M -17.52K
Capital Expenditures -3.52K -43.10K n/a
Acquisitions n/a n/a n/a
Purchase of Investments n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a
Other Investing Acitivies n/a n/a n/a
Investing Cash Flow -3.52K -43.10K n/a
Debt Repayment -167.46K 49.93K n/a
Common Stock Repurchased n/a n/a n/a
Dividend Paid n/a n/a n/a
Other Financial Acitivies 1.02M n/a 160.28K
Financial Cash Flow 7.06M 2.05M 40.07K
Net Cash Flow 56.15K 660.31K 22.55K
Free Cash Flow -7.00M -1.39M -17.52K